William Scott

ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY

INHIBITORS OF THE WNT SIGNALLING PATHWAYS

Compounds

Aryl ureas with angiogenisis inhibiting activity

Imidazopyridazines as Akt kinase inhibitors

Substituted pyrazolopyrimidines as Akt kinase inhibitors

Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

Substituted imidazopyrazines as Akt kinase inhibitors

6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines

Imidazopyridazines as Akt kinase inhibitors

Substituted imidazopyrazines

Substituted imidazo[1,2-a]pyrimidines and —pyridines

Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis

Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

INHIBITION OF P38 KINASE ACTIVITY BY ARYL UREAS

Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors

ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Diaryl ureas for diseases mediated by PDGFR